Zhou C, Wang Z, Sun M, Cao L, et al. Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): 4-year outcomes from a double-blind, randomised, phase 3 trial. Lancet Oncol 2025 Jun 13:S1470-2045(25)00198.
PMID: 40523368